Ignite Creation Date:
2024-05-06 @ 3:50 PM
Last Modification Date:
2024-10-26 @ 1:58 PM
Study NCT ID:
NCT04777071
Status:
RECRUITING
Last Update Posted:
2024-05-09
First Post:
2021-02-25
Brief Title:
An Investigational Scan 68Ga-PSMA-11 PET for the Imaging of Prostate Cancer
Sponsor:
University of Washington
Organization:
University of Washington
Study Overview
Official Title:
68Ga-PSMA-11 PET in Patients With Prostate Cancer
Status:
RECRUITING
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This trial studies how well 68Ga-PSMA-11 PET scan works in imaging patients with prostate cancer Diagnostic procedures such as 68Ga-PSMA-11 PET may find and diagnose prostate cancer and improve monitoring of treatment response
Detailed Description:
OUTLINE
Patients receive gallium Ga 68-labeled PSMA-11 intravenously IV then undergo PETCT or PETmagnetic resonance MR scan over 2-4 minutes per bed position at baseline Patients receiving systemic therapy undergo an additional 68Ga-PSMA-11 PETCT or PETMR scan 12 weeks after initiating therapy Patients may also undergo CT and bone scan during screening
After the completion of study patients are followed up at 60 days 6 months and annually up to 5 years or until time of first progression
Patients receive gallium Ga 68-labeled PSMA-11 intravenously IV then undergo PETCT or PETmagnetic resonance MR scan over 2-4 minutes per bed position at baseline Patients receiving systemic therapy undergo an additional 68Ga-PSMA-11 PETCT or PETMR scan 12 weeks after initiating therapy Patients may also undergo CT and bone scan during screening
After the completion of study patients are followed up at 60 days 6 months and annually up to 5 years or until time of first progression
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| NCI-2020-02612 | REGISTRY | None | None |
| 10512 | OTHER | Fred HutchUniversity of Washington Cancer Consortium | None |